Neuroprotective effects of mesenchymal stromal cells in mouse models of Alzheimer’s Disease: The Mediating role of gut microbes and their metabolites via the Microbiome-Gut-Brain axis
Brain, Behavior, and Immunity · 2024
DOI: 10.1016/j.bbi.2024.08.047 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain, Behavior, and Immunity, 2024. Verfasst von Cencan Xing und 18 weiteren Autor:innen. Beteiligte Einrichtung: Daxing Research Institute, School of Chemistry and Biological Engineering, University of Science and Technology Beijing, No. 30 XueYuan Road, Haidian…. Hauptthemen laut MEDLINE: Alzheimer Disease, Gastrointestinal Microbiome, Disease Models, Animal, Brain-Gut Axis. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 78 Literaturangaben. Gefördert von: Fundamental Research Funds for the Central Universities, University of Science and Technology Beijing, National Natural Science Foundation of China.
Themen: Demenz
Abstract (Originalsprache)
The intricacy and multifaceted nature of Alzheimer's disease (AD) necessitate therapies that target multiple aspects of the disease. Mesenchymal stromal cells (MSCs) emerge as potential agents to mitigate AD symptoms; however, whether their therapeutic efficacy involves modulation of gut microbiota and the microbiome-gut-brain axis (MGBA) remains unexplored. In this study, we evaluated the effects of three distinct MSCs types-derived from the umbilical cord (UCMSC), dental pulp (SHED), and adipose tissue (ADSC)-in an APP/PS1 mouse model of AD. In comparison to saline control, MSCs administration resulted in a significant reduction of behavioral disturbances, amyloid plaques, and phosphorylated tau in the hippocampus and frontal cortex, accompanied by an increase in neuronal count and Nissl body density across AD-afflicted brain regions. Through 16S rRNA gene sequencing, we identified partial restoration of gut microbial balance in AD mice post-MSCs treatment, evidenced by the elevation of neuroprotective Akkermansia and reduction of the AD-associated Sphingomonas. To examine whether gut microbiota involved in MSCs efficacy in treating AD, SHED with better anti-inflammatory and gut microbiota recovery effects among three MSCs, and another AD model 5 × FAD mice with earlier and more pathological proteins in brain than APP/PS1, were selected for further studies. Antibiotic-mediated gut microbial inactivation attenuated MSCs efficacy in 5 × FAD mice, implicating the involvement of gut microbiota in the therapeutic mechanism. Functional analysis of altered gut microbiota and targeted bile acid metabolism profiling revealed a significant enhancement in bile acid variety following MSCs therapy. A chief bile acid constituent, taurocholic acid (TCA), was orally administered to AD mice and similarly abated AD symptoms. Nonetheless, the disruption of intestinal neuronal integrity with enterotoxin abrogated the ameliorative impact of both MSCs and TCA treatments. Collectively, our findings substantiate that MSCs confer therapeutic benefits in AD within a paradigm that primarily involves regulation of gut microbiota and their metabolites through the MGBA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Daxing Research Institute, School of Chemistry and Biological Engineering, University of Science and Technology Beijing, No. 30 XueYuan Road, Haidian District, Beijing 100083, China.
- Daxing Research Institute, School of Chemistry and Biological Engineering, University of Science and Technology Beijing, No. 30 XueYuan Road, Haidian District, Beijing 100083, China; Shanghai Institute of Precision Medi…
- Daxing Research Institute, School of Chemistry and Biological Engineering, University of Science and Technology Beijing, No. 30 XueYuan Road, Haidian District, Beijing 100083, China; Reproductive Center, Peking Universi…
- Daxing Research Institute, School of Chemistry and Biological Engineering, University of Science and Technology Beijing, No. 30 XueYuan Road, Haidian District, Beijing 100083, China. Electronic address: starlitnightly@g…
- Daxing Research Institute, School of Chemistry and Biological Engineering, University of Science and Technology Beijing, No. 30 XueYuan Road, Haidian District, Beijing 100083, China. Electronic address: hongwudu@ustb.ed…
Förderung
- Fundamental Research Funds for the Central Universities
- University of Science and Technology Beijing
- National Natural Science Foundation of China
Zitieren
APA
Xing, C., Zhang, X., Wang, D., Chen, H., Gao, X., Sun, C., Guo, W., Roshan, S., Li, Y., Hang, Z., Cai, S., Lei, T., Bi, W., Hou, L., Li, L., Wu, Y., Li, L., Zeng, Z., & Du, H. (2024). Neuroprotective effects of mesenchymal stromal cells in mouse models of Alzheimer’s Disease: The Mediating role of gut microbes and their metabolites via the Microbiome-Gut-Brain axis. Brain, Behavior, and Immunity. https://doi.org/10.1016/j.bbi.2024.08.047
Vancouver
Xing C, Zhang X, Wang D, Chen H, Gao X, Sun C, et al. Neuroprotective effects of mesenchymal stromal cells in mouse models of Alzheimer’s Disease: The Mediating role of gut microbes and their metabolites via the Microbiome-Gut-Brain axis. Brain, Behavior, and Immunity. 2024. doi:10.1016/j.bbi.2024.08.047
BibTeX
@article{Xing2024,
author = {Xing, Cencan and Zhang, Xiaoshuang and Wang, Donghui and Chen, Hongyu and Gao, Xiaoyu and Sun, Chunbin and Guo, Wenhua and Roshan, Shah and Li, Yingxian and Hang, Zhongci and Cai, Shanglin and Lei, Tong and Bi, Wangyu and Hou, Liangxuan and Li, Luping and Wu, Yawen and Li, Liang and Zeng, Zehua and Du, Hongwu},
title = {Neuroprotective effects of mesenchymal stromal cells in mouse models of Alzheimer’s Disease: The Mediating role of gut microbes and their metabolites via the Microbiome-Gut-Brain axis},
journal = {Brain, Behavior, and Immunity},
year = {2024},
doi = {10.1016/j.bbi.2024.08.047}
}
EUVIMED